Fresenius Medical Care AG (FMS) Cash from Restructuring (2009 - 2018)

Fresenius Medical Care AG (FMS) has reported Cash from Restructuring for 6 consecutive years, with $51.4 million the latest figure, recorded in Q4 2018.

• In Q4 2018, Cash from Restructuring fell 14.47% year-over-year to $51.4 million; the TTM figure through Dec 2018 stood at $51.4 million (down 14.47% YoY), while the FY2018 annual figure was $51.4 million, down 14.47% from the prior year.
• Cash from Restructuring came in at $51.4 million for Q4 2018 at Fresenius Medical Care AG, up from $48.9 million in the prior quarter.
• The five-year high for Cash from Restructuring was $70.2 million in Q4 2016, with the low at $48.9 million in Q3 2018.
• Average Cash from Restructuring over 3 years is $59.5 million, with a median of $60.0 million recorded in 2017.
• Across the five-year window, Cash from Restructuring decreased 14.44% in 2017 and dropped 23.01% in 2018, its largest moves.
• Year by year, Cash from Restructuring stood at $70.2 million in 2016, then retreated by 14.44% to $60.0 million in 2017, then declined by 14.47% to $51.4 million in 2018.
• According to Business Quant data, Cash from Restructuring over the past three periods registered $51.4 million, $48.9 million, and $59.7 million for Q4 2018, Q3 2018, and Q2 2018 respectively.